Oncolytics Biotech Inc ONCY

Buyout Pool

[spesestsemper]

Please keep it light . Basically would like to get everyones opinion on what the buyout number would be if the company gets bought out.

My opinion is still $500 million

[Peladawn]

If they sell out for a mere $500 million, given the likely sales projections of over $5 billion in just one of three indications possible in just the near term, the entire board of directors should be immediately fired and sued, imho.

[Noteable]

ONCY has $500 million in R&D write-offs and the potential of $US 2.4 Billion in peak annual sales for the 3rd line HR+/HER2- breast cancer alone, and with 13 years of FDA market exclusivity from the approval date of pelareorep. And then there are 2 indications in PDAC, followed by anal cancer,  TNBC, CRC and GI cancer indications as follow-on approvals. So US$ 500 million would just

[jh1970]

I wish we get same offer like Regor Terapeutic $850M US. I wish that managment can honestly give us answer why ONC is not bought out yet.